PD-1 blockade in combination with zoledronic acid to enhance the antitumor efficacy in the breast cancer mouse model

BACKGROUND: Blockade of PD-1 receptor may provide proof of concepts for the activity of an immune-modulation approach for the treatment of breast cancer (BC). Zoledronic acid (ZA) has been proven to inhibit angiogenesis, invasion, and adhesion of tumor cells. The aim of this study was to investigate...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Yuan, Du, Yang, Sun, Ting, Xue, Huadan, Jin, Zhengyu, Tian, Jie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6009040/
https://www.ncbi.nlm.nih.gov/pubmed/29921237
http://dx.doi.org/10.1186/s12885-018-4412-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6009040/
https://www.ncbi.nlm.nih.gov/pubmed/29921237
http://dx.doi.org/10.1186/s12885-018-4412-8

Ejemplares similares